Screener
Travere Therapeutics, Inc. TVTX Operating Lease Liabilities
Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Travere Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.
The source filing: Travere Therapeutics, Inc.’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 4:45 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001438533-26-000042
| Assets | March 31, 2026 / (unaudited) | December 31, 2025 |
|---|---|---|
| Other current liabilities | 2,100 | 3,194 |
| Total current liabilities | 125,437 | 159,904 |
| Convertible debt | 312,079 | 311,724 |
| Operating lease liabilities, less current portion | 9,566 | 11,134 |
| Other non-current liabilities | 9,378 | 7,601 |
| Total liabilities | 456,460 | 490,363 |
| Commitments and Contingencies (See Note 13) | ||
| Stockholders' Equity: |
Item 1. Financial Statements
FAQ
- What is Travere Therapeutics, Inc.'s operating lease liabilities?
- Travere Therapeutics, Inc. (TVTX) reported operating lease liabilities of $9.57M in Q1 2026.
- How has Travere Therapeutics, Inc.'s operating lease liabilities changed year-over-year?
- Travere Therapeutics, Inc.'s operating lease liabilities decreased by 38.6% year-over-year, from $15.58M to $9.57M.
- What is the long-term trend for Travere Therapeutics, Inc.'s operating lease liabilities?
- Over 5 years (2020 to 2025), Travere Therapeutics, Inc.'s operating lease liabilities has grown at a -17.0% compound annual growth rate (CAGR), from $28.34M to $11.13M.
- What does operating lease liabilities mean?
- Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.
Ask your AI about Travere Therapeutics, Inc.'s operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude